Genmab A/S (GMAB)

AI Score

Unlock

19.51

0.19 (0.98%)

At close: Apr 15, 2025, 3:59 PM

19.58

0.34%

After-hours: Apr 15, 2025, 05:18 PM EDT

Dividends

No dividend history available for Genmab A/S.

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

GMAB News

15 hours ago · Genmab's Outlook Beyond Darzalex's Patent Cliff - seekingalpha.com
2 weeks ago · TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical Cancer - businesswire.com
2 weeks ago · Japanese Drug Regulator Approves Genmab Cancer Drug For Patients With Advanced Cervical Cancer - benzinga.com
2 weeks ago · TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy - businesswire.com
1 month ago · Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer - businesswire.com
1 month ago · Genmab: GEN3014's Demise And Implications For The HexaBody Platform - seekingalpha.com
1 month ago · Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38 - businesswire.com
1 month ago · Genmab: Positive 2025 Outlook, Johnson & Johnson's Decision Coming Soon - seekingalpha.com
2 months ago · Genmab A/S (GMAB) Q4 2024 Earnings Conference Call Transcript - seekingalpha.com
2 months ago · GMAB vs. QGEN: Which Stock Is the Better Value Option? - zacks.com